Align Names P&G Healthcare Chief Jennifer Davis CEO, Replacing Joe Hogan on December 31
ALGN sits 18% above its 52-week low of $130.23.
Summary
Align Technology appointed Jennifer L. Davis, former CEO of Procter & Gamble's global healthcare business, as President and CEO effective December 31, 2026, succeeding Joseph Hogan, who retires after leading the company since 2015.
Updates
· BusinessWire — Davis joins as CEO-elect and director on November 2, 2026, and Hogan retires from the Board after its June 16, 2027 strategy meeting.
- Archived audio webcast available 2 hours after the call's conclusion and remains available for one month
Key Events · Executive and Board Changes · ALGN
-
Davis Named CEO Effective December 31
Jennifer L. Davis becomes CEO-elect and a director on November 2, 2026, then President and CEO on December 31, 2026, succeeding Joseph M. Hogan.
-
Hogan Retires, Stays as Advisor
Hogan retires as President and CEO on December 31, 2026 and serves as a strategic advisor under a one-year consulting agreement paying $150,000 annually; he remains a non-independent director until June 2027.
-
New CEO Pay Package Disclosed
Davis receives a $1,300,000 base salary, a 150% target bonus, a $2,000,000 signing bonus, $16,500,000 of initial MSU/RSU awards, a 2027 equity target of at least $12,000,000, and up to $1,000,000 of tax-neutral relocation reimbursement.
-
Board Expanded to Eleven Directors
The board grows from ten to eleven members effective November 2, 2026, with Davis's initial term ending at the 2027 annual meeting.
Analysis · ALGN · Industrial Applications And Services
A CEO change at a $10.9B medical device company is a thesis-level event: the person setting strategy for Invisalign's next phase changes. Davis spent 33 years at Procter & Gamble, most recently running its global healthcare business, so the board is betting on consumer-brand and oral-health commercialization rather than clinical or engineering leadership. Hogan exits after leading since 2015 and stays on as a paid advisor through at least December 2027, which softens the handoff but also means the old strategy voice remains in the room. The pay package — $1.3M salary, $2M signing bonus, $16.5M of initial equity and a $12M 2027 equity target — is a real cost but immaterial against the company's scale. The open question is whether Davis keeps the current operating plan or resets priorities; the Q3 results released the same day give the first read on the business she inherits.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 38.5% of the 1020 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALGN was trading at $153.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $130.23 to $200.44. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.